High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome-Reference-Cited by-同舟云学术

High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome

Published:2019-12-19 Issue:7 Volume:146 Page:2007-2018
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wolf Dominik¹²,Fiegl Heidi³,Zeimet Alain G.³,Wieser Verena³^ORCID,Marth Christian³,Sprung Susanne⁴,Sopper Sieghart¹⁵,Hartmann Gunther⁶,Reimer Daniel³^ORCID,Boesch Maximilian⁷^ORCID

Affiliation:

1. Internal Medicine VMedical University of Innsbruck Innsbruck Austria

2. Medical Clinic III, Oncology, Hematology, Immuno‐Oncology and RheumatologyUniversity Clinic Bonn Bonn Germany

3. Department of Gynecology and ObstetricsMedical University of Innsbruck Innsbruck Austria

4. Department of PathologyMedical University of Innsbruck Innsbruck Austria

5. Tyrolean Cancer Research Institute Innsbruck Austria

6. Institute of Clinical Chemistry and Clinical PharmacologyUniversity Clinic Bonn Bonn Germany

7. Lung Center, Cantonal Hospital St. Gallen St. Gallen Switzerland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32818

Reference60 articles.

1. Epithelial ovarian cancer: prevention, diagnosis, and treatment

2. Cancer of the Ovary

3. The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics

4. Ovarian cancer stem cells

5. Rethinking ovarian cancer: recommendations for improving outcomes

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revitalizing antitumor immunity: Leveraging nucleic acid sensors as therapeutic targets;Cancer Letters;2024-04

2. Inhibition of DDX60 Expression Suppresses Oral Squamous Cell Carcinoma Growth and Enhances Radiosensitivity;J BIOL REG HOMEOS AG;2024

3. Autosurv: interpretable deep learning framework for cancer survival analysis incorporating clinical and multi-omics data;npj Precision Oncology;2024-01-05

4. MicroRNAs in the Regulation of RIG-I-like Receptor Signaling Pathway: Possible Strategy for Viral Infection and Cancer;Biomolecules;2023-09-04

5. RIG-I promotes cell proliferation in esophageal squamous cell carcinoma by facilitating p21 degradation;Medical Oncology;2023-09-01